Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Daniela Castelletti

1PUBLICATIONS

26CO-AUTHORS

Predictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jan 26, 2026

Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial.

Giampaolo Bianchini, Luca Malorni, Roberta Caputo

Pageof 1

Frequent Collaborators

1 joint publications

Giampaolo Bianchini

1 joint publications

Luca Malorni

1 joint publications

Roberta Caputo

1 joint publications

Alberto Zambelli

1 joint publications

Fabio Puglisi

1 joint publications

Giulia V Bianchi

1 joint publications

Lucia Del Mastro

1 joint publications

Ida Paris

1 joint publications

Filippo Montemurro

1 joint publications

Marco Colleoni

Frequent Collaborators

1 joint publications

Giampaolo Bianchini

1 joint publications

Luca Malorni

1 joint publications

Roberta Caputo

1 joint publications

Alberto Zambelli

Top Related Videos

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on : Dec 05, 2017

See more related videos

Top Related Videos

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on : Dec 05, 2017

See more related videos